U.S. FDA approves Amylin's diabetes drug

Jan 27, 2012   //   by   //   Blog  //  No Comments

First Check Out These Featured what can diabetics eat Solutions...


WASHINGTON (Reuters) – Amylin Pharmaceuticals Inc won U.S. approval on Friday for its Bydureon diabetes drug, a long-awaited victory for the company's most promising product. After two delays, the Food and Drug Administration approved once-weekly injectable Bydureon for treating adults with Type 2 diabetes, which is linked to poor diet and lack of exercise. Bydureon is a longer-acting form of …
Go to Source

Click Here To Check Out This what can diabetics eat Solution

No related posts.

Leave a comment

*

Featured Resources

RSS Follow us on Twitter

  • An error has occurred; the feed is probably down. Try again later.

Follow us on Facebook